Emma leads FleishmanHillard EU’s Health and Lifesciences team, providing public affairs and corporate communications sectoral expertise to clients. Emma has worked on high-profile pieces of EU health legislation, including the General Pharmaceutical Legislation and EU-wide HTA, and has a particular passion for supporting clients to develop patient advocacy engagement programmes. Situated in the heart of Europe’s healthcare policy, she also supports clients to manage multimarket environment shaping campaigns, ahead of product launch.
Before joining FleishmanHillard in 2015, Emma completed GSK’s Communications and Government Affairs Future Leadership Programme, with placements in the Pharmaceutical and Consumer Health businesses in London, UK, and Vaccines in Wavre, Belgium.
Emma holds a Bachelor of Arts (Honours) in French and Politics from the University of Newcastle-upon-Tyne. She speaks English and French and has a basic knowledge of Dutch.